Skip to main content

RXi Shares Begin Trading on OTCQX Exchange

Premium

RXi Pharmaceuticals last week announced that its stock has begun trading on the OTCQX stock exchange.

According to the company, this over-the-counter exchange is reserved for “high-quality U.S. companies that meet financial standards, undergo management reviews and provide timely news and disclosure to investors.”

RXi had at one time traded on the Nasdaq, but lost its listing when it merged with Apthera in 2011. The new company changed its name to Galena, took RXi’s stock listing, and made RXi a subsidiary. RXi was later spun out as a publicly traded independent company again, but traded on the over-the-counter bulletin board (GSN 4/26/2012).

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.